Vitrolife ABFRA:VTFN -0.83%78 OCF Margin % is 21.31% as of Mar. 2026, which is 11% below its 10-year median of 23.99. GuruFocus rates FRA:VTFN with a GF Score™ of 78/100 and a GF Value™ of €14.38 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Vitrolife AB ranks better than 83.44% on this metric.
The historical rank and industry rank for Vitrolife AB's OCF Margin % or its related term are showing as below:
FRA:VTFN'
s OCF Margin % Range Over the Past 10 Years
Min: 18.46 Med: 23.99 Max: 30.35
Current: 21.67
During the past 13 years, the highest OCF Margin % of Vitrolife AB was 30.35%. The lowest was 18.46%. And the median was 23.99%.
FRA:VTFN's OCF Margin % is ranked better than 83.44% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs FRA:VTFN: 21.67
Vitrolife AB OCF Margin % Related Terms
Vitrolife AB OCF Margin % Historical Data
* Premium members only.
The historical data trend for Vitrolife AB's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VTFN vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Vitrolife AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitrolife AB OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Vitrolife AB's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitrolife AB (FRA:VTFN) has a OCF Margin % of 21.31% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vitrolife AB and its competitors. This is 11% below median its historical median of 23.99. Over the past decade, Vitrolife AB's OCF Margin % has ranged from 18.46 to 30.35. According to the industry distribution chart, Vitrolife AB ranks #135 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 16.6%.
Is Vitrolife AB's OCF Margin % too high?
Vitrolife AB's current OCF Margin % of 21.31% is 11% below median its 10-year median of 23.99. Over the past 10 years, this metric has ranged from a low of 18.46 to a high of 30.35. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Vitrolife AB's value of 21.31% is 263.7% above this industry median. Based on the distribution chart, Vitrolife AB ranks #135 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vitrolife AB has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vitrolife AB ranks #135 out of 815 companies for OCF Margin %. This places Vitrolife AB in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Vitrolife AB's value of 21.31% is 263.7% above this benchmark. Historically, Vitrolife AB's own OCF Margin % has ranged from 18.46 to 30.35 over the past decade. While the company's 10-year median is 23.99 vs. the industry median of 5.86, Vitrolife AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitrolife AB's current OCF Margin % of 21.31% is 263.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vitrolife AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitrolife AB's current OCF Margin % is 21.31%, which is 11% below median its own 10-year median of 23.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (FRA:VTFN) is currently considered Possible Value Trap. The stock's GF Value™ is €14.38, compared to a current price of €7.75 — trading 46.1% below its estimated fair value. The current OCF Margin % is 21.31%, which is 11% below median its 10-year median of 23.99 and 263.7% above the Medical Devices & Instruments industry median of 5.86. Vitrolife AB's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vitrolife AB (FRA:VTFN), the current OCF Margin % is 21.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vitrolife AB (FRA:VTFN) Overvalued in 2026?
Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued.
The current stock price of €7.75 is trading 46.1% below its estimated GF Value™ of €14.38.
GuruFocus considers Vitrolife AB to be Possible Value Trap.
Key valuation signals for FRA:VTFN:
OCF Margin %: 21.31% (11% below median its 10-year median of 23.99)
GF Value™: €14.38 vs. price of €7.75 (46.1% below fair value)
Industry Position: 263.7% above the Medical Devices & Instruments median (#135 of 815)
No single metric tells the full story. See the FRA:VTFN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
78GF Score
Get the complete analysis for FRA:VTFN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VTFN has been successfully added to your 
